Reported Earlier, Corvus Pharmaceuticals Publishes Preclinical Data Demonstrating Potential Of ITK Inhibition With Soquelitinib As A Novel Approach To T Cell-Mediated Inflammatory And Immune Diseases
Author: Benzinga Newsdesk | November 02, 2023 02:32am